Credit Suisse said on Friday it would put aside more funds for a U.S. probe and other litigation about whether the Swiss bank deceived investors in risky mortgage-backed securities it had issued in the run-up to the financial crisis.
A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium and the antiviral Valcyte, a court document showed.
The U.S. Supreme Court on Wednesday ruled that a North Carolina state dental board does not have the authority to regulate teeth-whitening services, accepting the federal government’s claim that the system is anticompetitive because dentists sit on the panel.
A former hedge fund manager on Thursday sued U.S. law enforcement officials, including Manhattan U.S. Attorney Preet Bharara, claiming the government improperly raided his offices and destroyed his business as part of a widespread insider trading crackdown.
